ABLATION CATHETER WITH RADIAL FORCE DETECTION

(19)

(11)

EP 3 178 428 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	20.07.2022 Bulletin 2022/29

(45)	Mention of the grant of the patent:
	08.06.2022 Bulletin 2022/23

(21)	Application number: 16200409.7

(22)	Date of filing: 24.11.2016

(51)

International Patent Classification (IPC):

A61B 18/14^(2006.01)

(52)	Cooperative Patent Classification (CPC):
	A61B 2018/00029; A61B 2018/0016; A61B 2018/00357; A61B 2090/065; A61B 18/1492; A61B 2018/00577; A61B 2218/002

(54)	ABLATION CATHETER WITH RADIAL FORCE DETECTION ABLATIONSKATHETER MIT RADIALKRAFTDETEKTION CATHÉTER D'ABLATION AVEC DÉTECTION DE FORCE RADIALE

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
	Designated Extension States:
	BA ME

(30)

Priority:

25.11.2015 US 201514951907

(43)	Date of publication of application:
	14.06.2017 Bulletin 2017/24

(73)	Proprietor: Biosense Webster (Israel) Ltd.
	Yokneam 2066717 (IL)

(72)	Inventor:
	O'FALLON, Patrick Irwindale, CA 91706 (US)

(74)	Representative: Carpmaels & Ransford LLP
	One Southampton Row London WC1B 5HA London WC1B 5HA (GB)

(56)

References cited: :

EP-A1- 2 664 295
US-A1- 2012 259 194

US-A1- 2002 123 749
US-A1- 2015 300 895

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).